Panel members - NHS Cancer Programme Innovation Open Call 3
Professor Paula Ghaneh (Chair)
Professor, University of Liverpool
Pancreatic surgery, pancreatic cancer, clinical trials, biomarkers.
Dr Neville Young (Co-Chair)
Director of Enterprise & Innovation, Health Innovation Yorkshire & Humber
Cancer, Innovation, technology, Health and Life Sciences, Regulation, Business Development, Commercials.
Dr Sonia Ashraf
Deputy Clinical Director, West Midlands Cancer Alliance
Cancer Screening, Primary care cancer delivery, PCN cancer DES delivery, Cancer QOF delivery, Clinical Cancer pathway redesign, Cancer quality, Early cancer diagnosis and Cancer referrals.
Professor John Chester
Director of Research & Innovation, Alder Hey Children's NHS Foundation Trust, Liverpool
Professor John Hutton
Retired, YHEC, University of YorkHealth
Health economics, health technology assessment.
Professor David Jayne
Professor of Surgery, University of Leeds
Surgery, Gastrointestinal cancer (colorectal), clinical trials, technology evaluation.
Mr Dave Kelsall
Public Contributor
Cancer survivor - diagnosed in 2013 with Stage 4 Cancer of the Oesophageal-Gastric junction. Palliative Chemo started the process of shrinking the cancer and over time my immune system finished the job. By 2020 there were no visible signs of cancer to report during my six-monthly CT scan. Volunteer with Cancer Research UK on their Health Awareness Roadshow. Certified IT Professional - specialising in Health Technology with operational experience as an NHS Chief Information Officer with a USP of combining this with hands-on procurement experience.
Dr Priya Kumar
GP Partner & Health Inequalities Lead, Kumar Medical Centre and Transformational Clinical Digital Lead for the Connected Care, Frimley ICB
Primary Care, Health Inequalities, Digital, Urgent Care, Transformation, Population Health Management.
Dr Sonja Marjanovic
Director - Healthcare Innovation, Industry and Policy, RAND Europe
Innovation, service improvement, digital health, oncology.
Dr Sarah Byron
Programme Director HealthTech, National Institute for Health and Care Excellence
Dr Smitha Nathan
Associate Director, South East London Cancer Alliance
Mrs Claire O'Rourke
Managing Director, Greater Manchester Cancer
NHS Senior Management in Cancer for 24 years. Previous Oncology Nurse, leadership of GM Cancer Alliance and ICB Programme Director and led in Greater Manchester.
Mrs Jan Digby Speechley
Public Contributor
PPIE Lived Experience Expert and Public Reviewer
Mr Nishan Sunthares
Executive Director, Diagnostics, Association of British HealthTech Industries
Diagnostics research and development, market access, funding and investment. Health policy and government working.
Dr Claire Taylor, MBE
Chief Nursing Officer, Macmillan Cancer Support
GI cancer/ Nursing/ Survivorship/ Colorectal surgery/Quality of life/ Behaviour change/ Patient experience.
Mr Naser Turabi
Director of Evidence and Implementation, Cancer Research UK
Health services management, innovation, cancer, inequalities.
Mrs Elaine Warburton
Chair, ReadyGo Diagnostics Ltd
Specialist in commercialising new technologies and services into mainstream medicine. Serial entrepreneur having taken several companies from ideation to exit as CEO, CFO or Chair. Expert in molecular diagnostics particularly point of care diagnostics. Former hospital Executive. Chartered accountant, nurse and geneticist by training.
Mrs Doris-Ann Williams
Industry Consultant
IVD - use and adoption of innovation of in the NHS in both laboratories and at point of care. Regulation of IVD products.
Ms Linda Wolstenholme
Public Contributor
NHS commissioning and bidding. Recently evaluated 47 Cancer Alliance Innovation bids. Also worked with NHSE team evaluating bids relating to the 'Galleri' pilot.